CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF)
CUSIP: G1933S101
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Ordinary Shares
- Shares outstanding
- 35,821,764
- Total 13F shares
- 275,894
- Share change
- -68,714
- Total reported value
- $1,981,066
- Put/Call ratio
- 57%
- Price per share
- $7.16
- Number of holders
- 17
- Value change
- -$338,820
- Number of buys
- 3
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP G1933S101?
CUSIP G1933S101 identifies CASIF - CASI Pharmaceuticals, Inc. - Ordinary Shares in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP G1933S101:
Top shareholders of CASIF - CASI Pharmaceuticals, Inc. - Ordinary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Wellington Shields Capital Management, LLC |
13F
|
Company |
0.43%
|
153,455
|
$392,845 | — | 30 Sep 2023 | |
| Wellington Shields & Co., LLC |
13F
|
Company |
0.21%
|
74,166
|
$189,865 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.09%
|
32,365
|
$82,854 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
22,221
|
$56,885 | — | 30 Sep 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.06%
|
22,124
|
$56,637 | — | 30 Sep 2023 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.06%
|
19,777
|
$50,629 | — | 30 Sep 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.05%
|
17,800
|
$46,000 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,553
|
$3,976 | — | 30 Sep 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
328
|
$840 | — | 30 Sep 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
327
|
$837 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
324
|
$829 | — | 30 Sep 2023 | |
| WEST PACES ADVISORS INC. |
13F
|
Company |
0%
|
100
|
$256 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
25
|
$64 | — | 30 Sep 2023 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
13
|
$33 | — | 30 Sep 2023 | |
| Colonial Trust Co / SC |
13F
|
Company |
0%
|
11
|
$28 | — | 30 Sep 2023 | |
| Kozak & Associates, Inc. |
13F
|
Company |
0%
|
10
|
$27 | — | 30 Sep 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
6
|
$15 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
3
|
$8 | — | 30 Sep 2023 |
Institutional Holders of CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF) as of Q4 2023
As of 31 Dec 2023,
CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
275,894 shares.
The largest 10 holders included
Wellington Shields Capital Management, LLC, Wellington Shields & Co., LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, FRANKLIN RESOURCES INC, CITADEL ADVISORS LLC, JANE STREET GROUP, LLC, MORGAN STANLEY, UBS Group AG, and BlackRock Inc..
This page lists
17
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
18
Q4 2023 holders
17
Holder diff
-1
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.